By a conservative estimate, at least 400 million people, most of them from Africa and Asia, are suffering from malnutrition today. Ten million of these, mostly children under the age of five yr, die annually. Death in these children is usually due to secondary infection associated with the diminished immune responses that have been reported by several authors (2, 4, 6, 8, 9, 11) . At a Workshop on the Immunology of malnutrition held during the Third International Congress of Immunology in Sydney, Australia in July 1977, it was generally believed that the information derived from the immunology of malnutrition should be channelled towards the management of children with protein-energy malnutrition. In response to this, the authors decided to investigate the effects of levamisole (Ketrax), a known immuno-stimulatory agent on the immune response of experimentally malnourished rats.
MATERIALS AND METHODS

ANIMALS
Male white albino rats (Rattus rattus norvegicus) were used for this study. They were bred in the Animal House of the Faculty of Health Sciences, University of Ife.
Levamisole (trade name, Ketrax) was obtained from the Pharmacy Department of the University of Ife Teaching Hospitals Complex. The preparation used was in syrup. Five ml of the syrup contains 40 mg levamisole as hydrochloride. Ketrax is manufactured by Imperial Chemicals Industry, Pharmaceuticals Division, Macclesfield, Cheshire, England.
Sheep blood was obtained from the Agricultural farm of the University of Ife. After centrifugation, sheep red blood cells were washed in sterile Hank's balanced salt solution and stored in the solution containing 2% fetal bovine serum and penicillin at 4OC. Mouse cube diet and Average Grade baker's flour were used in the present study. Their compositions have been given in a previous publication (1 1). Achitina fulica hemocyanin was obtained from the Giant African Snail as described in a previous publication (12).
DOSE OF LEVAMISOLE
From reports in the literature, most investigators working on the immunostimulatory effects of levamisole in experimental animals have usually employed 5 mg/kg body wt. In view of the impaired immunologic responses in malnutrition, it was decided to use levamisole in doses of 10 mg/kg body wt.
ADMINISTRATION OF LEVAMISOLE
Levamisole was given orally to the rats by means of a gastric tube. The animal was held in an upright position while the polythene tubing was gently passed into the stomach, the animal exhibiting a characteristic gagging when the tube was in the stomach. The required dose of levamisole was then gently injected through a syringe attached to the tubing.
EXPERIMENTAL DESIGN
Male white albino rats were malnourished by feeding them on flour diet for two months. The malnourished animals were than randomized into four groups, each group consisting of 12 animals. The animals in group A (the controls) continued to be fed on the flour diet. The animals in group B were refed on the standard laboratory mouse cube diet.
The animals in group C were fed on the flour diet but, in addition, they received 10 mg/kg body wt levamisole on alternate days for 30 days so that each animal received 15 doses of the drug during this period. The animals in group D were refed on the high protein mouse cube diet but, in addition, they had levamisole on alternate days for 30 days.
After this period of 30 days, the primary humoral immune response was assessed using six animals from each group of rats by estimating the number of plaque-forming cells in the spleen five days after intraperitoneal immunization with sheep red blood cells using the method described in a previous publication (I I). Cell-mediated immunity was assessed by estimating the number of spontaneous rosette-forming cells in the peripheral blood of the animals using the method described by Higgins and Stack (5). Delayed type hypersensitivity skin reactions to hemocyamin were assessed using the remaining six animals from each group.
The method used for skin testing has been described in a previous publication (10) .
Histologic sections of the spleen and thymus (where present) from a representative of each group of rats were made and thymic cortical thickness and diameter of the Hassall's corpuscles were estimated using the micrometer eyepiece. Thymic cell counts were also made by dispersing a piece of the thymus in Hank's balanced salt solution and counting the number of cells on a hemocytometer chamber.
Statistical analyses of results were camed out according to the methods described by Lutz (7) .
RESULTS
The results obtained are presented in Tables 1 and 2; Table 1 shows that levamisole, at the dose employed in this study had no significant effect ( P > 0.05) on the number of plaque-forming cells to sheep erythrocytes either in normal or malnourished rats. From Table 2 , it could be deduced that malnutrition causes atrophy of the thymus gland and a significant reduction in the number of spontaneous rosette-forming lymphocytes in the peripheral circulation. When malnourished rats were treated with levamisole alone for 30 days a significant increase ( P < 0.05) occurred in thymic weight, cell count, and cortical thickness. In addition, the drug caused a significant increase in the number of spontaneous rosette-forming lymphocytes and improvement in delayed type hypersensitivity skin reaction to hemocynin. Table 2 also shows that the effects on the histology of the thymus and cell mediated immunity of refeeding the malnourished rats with a high protein diet were superior to those obtained when levamisole alone was used. However, a combination of levamisole and refeeding on high protein diet produced significantly more marked improvements in cell-mediated immune responses than refeeding on a high protein diet alone.
DISCUSSION
The results of this study showed that treatment of malnourished rats with levamisole resulted in marked improvement in cellular immunity but that such improvement was inferior to that produced by refeeding on a high protein diet. Combination of levamisole with a high protein diet on the other hand produced more marked improvement on cellular immunity than refeeding on a high protein diet alsne.
There is no doubt that the best treatment for malnutrition is an improved diet. But it is known that in certain cases of kwashiorkor, treatment with a high protein diet often results in overwhelming infections due to the severely diminished cellular immunity. It is in these cases that treatment with levamisole may prove useful.
Levamisole is a synthetic compound and is the L-isomer of racemic tetramisole. It is a simple chemical compound-2,3,5,6-tetrahydro-6-phenyl-imidazo (2,l-b) thiazole. It is a nematocidal drug that causes the death of the nematodes by producing muscular paralysis associated with inhibition of an enzyme called fumarase reductase. Because its discovery and subsequent uses in the treatment of worm infestations in man, certain reports have indicated that it may have some immunostimulatory effects. Among the earliest reports of its immunostimulatory property were its restoration of antibacterial immunity (14) and increase graft versus host reaction in F hybrid recipients after inoculation of spleen cells from a parental donor previously stimulated by iniection of levamisole (13) . Reports have also shown that it restored cutaneous delayed hypdrsensitivity reaction in elderly subjects (20) and in anergic patients with cancer (17) . It has been used in the treatment of recurrent aphtheous stomatitis and herpes infections (16) and in the prevention of upper respiratory tract infection in children (18) . This study shows that it improved cellular immunity in malnourished animals and may, therefore, be useful in the treatment of severe cases of malnutrition.
Our findings that levamisole influences cell-mediated and not humoral immunity agree with previous reports (3, 19, 21, 22) . In spite of the extensive literature on the immunostimulatory effects of levamisole, its mode of action is not known (15) . The facts that levamisole, in this study, caused increases in thymic weight, cell count, cortical thickness, and the number of Hassall's corvuscles would tend to suggest that levamisole stimulates the thymuigland. Such stimulation might lead to the ~roduction of thymic hormones " that, in turn, stimulate cell-mediated immune reactions. Further studies are being continued by us on a clinical trial involving the use of levamisole in the treatment of children with kwashiorkor.
